Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Drugs for Melanoma

Braftovi (encorafenib) & Mektovi (binimetinib)

Drug company: Pfizer
877-744-5675

Pfizer Oncology Together offers 2 financial assistance programs for patients who have been prescribed Braftovi + Mektovi:

Pfizer Oncology Together Co-Pay Savings Program

Pfizer Patient Assistance Program

Cotellic (cobimetinib) Tablets

Drug company: Genentech
866-422-2377

Genentech Oncology offers 2 financial assistance programs for patients using Cotellic:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Imlygic (talimogene laherparepvec) Injection

Drug company: Amgen
888-427-7478

Amgen Assist 360 offers 2 financial assistance programs for patients using Imlygic:

Amgen Support Co-Pay Program

Amgen Safety Net Foundation

Keytruda (pembrolizumab)

Drug company: Merck
855-257-3932

Merck offers 2 financial assistance programs for patients using Keytruda:

Merck Co-pay Assistance Program

Merck Patient Assistance Program

Kimmtrak (tebentafusp-tebn)

Drug company: Immunocore
844-775-2273

Immunocore offers 1 financial assistance program for patients using Kimmtrak:

Kimmtrak Connect

Mekinist (trametinib) Tablets

Drug company: Novartis
800-282-7630

Novartis Patient Assistance Now Oncology offers 2 financial assistance programs for patients using Mekinist:

Novartis Oncology Universal Co-pay Program

Novartis Patient Assistance Foundation

Opdivo (nivolumab)

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Opdivo:

BMS Oncology Co-Pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Opdualag (nivolumab and relatlimab-rmbw)

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Opdualag:

BMS Oncology Co-Pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Tafinlar (dabrafenib) Capsules

Drug company: Novartis
800-282-7630

Novartis Patient Assistance NOW Oncology offers 2 financial assistance programs for patients using Tafinlar:

Novartis Oncology Universal Co-pay Program

Novartis Patient Assistance Foundation

Tecentriq (atezolizumab)

Drug company: Genentech
866-422-2377

Genentech Oncology offers 2 financial assistance programs for patients who have been prescribed Tecentriq:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Yervoy (ipilimumab)

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Yervoy:

BMS Oncology Co-Pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Zelboraf (vemurafenib) Tablets

Drug company: Genentech
866-422-2377

Genentech Oncology offers 2 financial assistance programs for patients using Zelboraf:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation